Bridge Medicines signs agreement with Weill Cornell Medicine to develop novel S1P receptor modulator March 12, 2019 No Comments
Sunshine Lake Pharma identifies new semicarbazide-sensitive amine oxidase inhibitors Feb. 28, 2019 No Comments
Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury Feb. 28, 2019 No Comments
Nicotinamide N-methyltransferase inhibitor enhances aged muscle regeneration Feb. 27, 2019 No Comments
RSS